IPAD-DB ID | S01235 |
Name | Azure A |
Category | Synthetic compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 4 H 1 4 C l N 3 S |
Molecular Weight | 291.8 g/mol |
IUPAC Name | (7-aminophenothiazin-3-ylidene)-dimethylazanium;chloride |
InChI | InChI=1S/C14H13N3S.ClH/c1-17(2)10-4-6-12-14(8-10)18-13-7-9(15)3-5-11(13)16-12;/h3-8, 15H, 1-2H3;1H |
InChIKey | NALREUIWICQLPS-UHFFFAOYSA-N |
Canonical SMILES | C[N+](=C1C=CC2=NC3=C(C=C(C=C3)N)SC2=C1)C.[Cl-] |
PubChem CID | 13735 |
DrugBank Accession Number | - |
CAS Registry Number | 531-53-3 |
Molecular Weight(Computed by SwissADME) | 291.8 |
Hac(Computed by SwissADME) | 19 |
Volume(Computed by ADMETlab 2.0) | 259.393 |
Density(Computed by ADMETlab 2.0) | 0.987 |
nRing(Computed by ADMETlab 2.0) | 3 |
MaxRing(Computed by ADMETlab 2.0) | 14 |
nHet(Computed by ADMETlab 2.0) | 4 |
fChar(Computed by ADMETlab 2.0) | 1 |
nRig(Computed by ADMETlab 2.0) | 17 |
Flexibility(Computed by ADMETlab 2.0) | 0 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -1.248 |
LogD(Computed by ADMETlab 2.0) | 1.309 |
logP(Computed by ADMETlab 2.0) | 1.312 |
TPSA(Computed by SwissADME) | 70.16 |
Hbond Acceptor(Computed by SwissADME) | 1 |
Hbond Donor(Computed by SwissADME) | 1 |
Rotatable Bonds(Computed by SwissADME) | 0 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | Yes |
CYP1A2 Inhibitor(Computed by SwissADME) | No |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -6.49 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 1 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 0 |
Bioavailability Score(Computed by SwissADME) | 0.55 |